Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2.
Bellavita R, Esposito S, Braccia S, Madrid L, Ortega P, D'Auria G, Zarrilli F, Amato F, Galdiero S, de la Mata J, Falcigno L, Falanga A.
Bellavita R, et al. Among authors: falcigno l.
Int J Pharm. 2024 Aug 15;661:124389. doi: 10.1016/j.ijpharm.2024.124389. Epub 2024 Jun 26.
Int J Pharm. 2024.
PMID: 38942185
Free article.